Latest 窪蹋勛圖厙 News Stories
FDAs Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDAs plans to streamline regulation of biosimilars, which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
In Mississippi, Medicaid Coverage of Weight Loss Drugs Fails To Catch On
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
Listen: Why ‘TrumpRx’ Might Not Save You Money
On the “Today, Explained” podcast, 窪蹋勛圖厙 News’ Julie Rovner recaps the TrumpRx announcement and why the direct-to-consumer initiative may not save you money on prescription drugs if you have insurance through your employer or the government.
What the Health? From 窪蹋勛圖厙 News: Public Health Further Politicized Under the Threat of More Firings
In a rambling news conference that shocked public health experts, President Donald Trump without scientific evidence blamed the over-the-counter drug acetaminophen, and too many childhood vaccines, for the increase in autism diagnoses in the U.S. That came days after a key immunization advisory panel, newly reconstituted with vaccine doubters, changed several long-standing recommendations. Former Centers for Disease Control and Prevention official Demetre Daskalakis joins 窪蹋勛圖厙 News Julie Rovner to discuss those stories. Meanwhile, Sandhya Raman of CQ Roll Call and Anna Edney of Bloomberg News join Rovner with the rest of the news, including a threat by the Trump administration to fire rather than furlough federal workers if Congress fails to fund the government beyond the Oct. 1 start of the new fiscal year.
Why Are More Older People Dying After Falls?
Some researchers suspect that rising prescription drug use may explain a disturbing trend.
聶Por qu矇 mueren m獺s personas mayores despu矇s de sufrir ca穩das?
En 2023, el a簽o m獺s reciente con datos disponibles de los Centros para el Control y Prevenci籀n de Enfermedades (CDC), m獺s de 41.000 personas mayores de 65 a簽os murieron por ca穩das.
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesnt make sense, former officials said.
What the Health? From 窪蹋勛圖厙 News: Countdown to Government Shutdown
With less than three weeks before the deadline to pass legislation to keep the federal government running, lawmakers are still far apart on a strategy. Democrats hope Republicans will agree to extend expanded tax credits for the Affordable Care Act as part of a compromise, but so far Republicans are not negotiating. Meanwhile, HHS Secretary Robert F. Kennedy Jr. released his long-awaited Make America Healthy Again report, with few specific action items. Anna Edney of Bloomberg News, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join 窪蹋勛圖厙 News Julie Rovner to discuss these stories and more.
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether and how to taper patients off expensive GLP-1 drugs.
Breaking Down Why Medicare Part D Premiums Are Likely To Go Up
Insurers will take drug costs, frequency of use, and other factors into account as they set premium amounts for the 2026 plan year.
What the Health? From 窪蹋勛圖厙 News: Kennedy Cancels Vaccine Funding
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but its unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join 窪蹋勛圖厙 News Emmarie Huetteman to discuss these stories and more.
An Arm and a Leg: The Prescription Drug Playbook, Part II
In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
Journalists Break Down Reconciliation Bill, Vaccine Panel Meeting, and ‘Dobbs’ Anniversary
窪蹋勛圖厙 News journalists made the rounds on national and local media recently to discuss topical stories. Heres a collection of their appearances.
An Arm and a Leg: The Prescription Drug Playbook, Part I
In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesitys Complexity
A new drug is helping families whove spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress and a broader understanding of obesity is now under threat as the government dismantles the pipeline for promising new research.
Trump Wont Force Medicaid To Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
Late last year, South Carolina Medicaid approved a class of medications known as GLP-1s to treat obesity, placing it among the few state programs covering these effective but expensive drugs. But access remains limited, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.
Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
According to the timeline in the May 12 executive order, prescription drug price reductions would not happen “almost immediately, but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs which account for 90% of U.S. prescriptions see trouble ahead for patients.
What the Health? From 窪蹋勛圖厙 News: GOP Tries To Cut Billions in Health Benefits
GOP-controlled House committees approved parts of President Donald Trumps one big, beautiful bill this week, including more than $700 billion in cuts to health programs over the next decade mostly from Medicaid, which covers people with low incomes or disabilities. Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress for the first time since taking office and told lawmakers that Americans shouldnt take medical advice from him. Julie Appleby of 窪蹋勛圖厙 News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join 窪蹋勛圖厙 News Julie Rovner to discuss these stories and more.
Pain Clinic CEO Faced 20 Years for Making Patients ‘Human Pin Cushions.’ He Got 18 Months.
Michael Kestner, CEO of Pain MD, was convicted of 13 fraud felonies after his company gave patients hundreds of thousands of questionable injections at clinics in Tennessee, Virginia, and North Carolina.
